Related Experiment Videos
Pancreatic and ampullary carcinoma
1Department of Gastroenterology and Hepatology, University of Amsterdam, The Netherlands.
Gastrointestinal Endoscopy Clinics of North America
|January 1, 1995
Summary
For pancreatic and ampullary carcinoma, surgery offers curative potential. Palliative endoscopic therapy is preferred for unresectable tumors, balancing initial relief against long-term outcomes.
Area of Science:
- Gastroenterology
- Surgical Oncology
Background:
- Pancreatic and ampullary carcinomas require timely therapeutic decisions.
- Surgery is the primary curative and palliative option for duodenal obstruction.
- Palliative care is essential for unresectable or inoperable tumors.
Purpose of the Study:
- To compare the efficacy and outcomes of surgical versus endoscopic palliative therapies for pancreatic and ampullary carcinoma.
- To evaluate long-term palliation and survival rates between treatment modalities.
Main Methods:
- Comparative analysis of surgical (including palliative bypass) and endoscopic stenting therapies.
- Review of initial jaundice relief, mortality, complication rates, and long-term outcomes.
- Consideration of patient survival predictions and preferences.
Main Results:
- Both surgery and endoscopic therapy provide equal initial jaundice relief.
- Surgery has higher initial mortality and complications; endoscopy has more long-term issues.
- No significant difference in overall patient survival was observed between the groups.
Conclusions:
- Patient selection is crucial: nonsurgical therapy for poor short-term prognosis, surgery for longer life expectancy.
- Endoscopic therapy may offer poorer long-term palliation despite lower initial risks.
- Laparoscopic cholecystojejunostomy shows promise for malignant biliary obstruction palliation.